A more recent study finds that treatment with murine IFN-α (250 IU/day) for 14 days results in a reproducible depression-like state that can be characterized by increased immobility of C57BL6/J mice in TST and FST37. This evidence concerns the gene IFNA2 and depressive symptom measurement.